A genetic tool for the longitudinal study of a subset of post-inflammatory reactive astrocytes.
A genetic tool for the longitudinal study of a subset of post-inflammatory reactive astrocytes.
复制标题
DOI:
10.1016/j.crmeth.2022.100276
复制
发表时间:
2022-08-22
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Astrocytes are vital support cells that ensure proper brain function. In brain disease, astrocytes reprogram into a reactive state that alters many of their cellular roles. A long-standing question in the field is whether downregulation of reactive astrocyte (RA) markers during resolution of inflammation is because these astrocytes revert back to a non-reactive state or die and are replaced. This has proven difficult to answer mainly because existing genetic tools cannot distinguish between healthy versus RAs. Here we describe the generation of an inducible genetic tool that can be used to specifically target and label a subset of RAs. Longitudinal analysis of an acute inflammation model using this tool revealed that the previously observed downregulation of RA markers after inflammation is likely due to changes in gene expression and not because of cell death. Our findings suggest that cellular changes associated with astrogliosis after acute inflammation are largely reversible. An inducible Cre line to selectively target a subset of reactive astrocytes (RAs) Cre is expressed in RAs across a wide array of brain inflammation models Enables the permanent tagging of RAs for longitudinal analysis RAs largely revert to a non-reactive state 1 month after acute inflammation In vivo study of reactive astrocytes (RAs) has proven difficult mainly because existing genetic tools using traditional astrocyte promoters cannot distinguish between healthy versus reactive astrocytes. To fill this gap, we describe the generation and characterization of an inducible genetic tool that can be used to specifically target, label, and manipulate a subset of RAs in the diseased or injured brain. We provide evidence for the utility of this approach to study RAs in several models of brain inflammation. Agnew-Svoboda et al. generate an inducible Cre line to enable selective targeting and manipulation of a subset of reactive astrocytes (RAs) in brain disease. Longitudinal analysis of RAs reveal that astrocytes that become reactive soon after acute inflammation survive but largely revert to a non-reactive state once inflammation has resolved.